Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DMN NASDAQ:GROM NASDAQ:KBNT NASDAQ:KLDO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDMNGrafiti$0.03$0.00▼$4.95$3.84M0.04231.68 million shs8 shsGROMGrom Social Enterprises$0.00$0.00$0.00▼$0.00$1K1.5299,613 shs235 shsKBNTKubient$0.00$0.00$0.00▼$0.01$1K0.794,171 shs1,770 shsKLDOKaleido Biosciences$0.00$0.00$0.00▼$0.35$4K-0.062,293 shs865 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDMNGrafiti0.00%0.00%-99.23%-99.53%-97.33%GROMGrom Social Enterprises-50.00%0.00%0.00%0.00%-88.89%KBNTKubient0.00%0.00%0.00%0.00%0.00%KLDOKaleido Biosciences0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDMNGrafiti$0.03$0.00▼$4.95$3.84M0.04231.68 million shs8 shsGROMGrom Social Enterprises$0.00$0.00$0.00▼$0.00$1K1.5299,613 shs235 shsKBNTKubient$0.00$0.00$0.00▼$0.01$1K0.794,171 shs1,770 shsKLDOKaleido Biosciences$0.00$0.00$0.00▼$0.35$4K-0.062,293 shs865 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDMNGrafiti0.00%0.00%-99.23%-99.53%-97.33%GROMGrom Social Enterprises-50.00%0.00%0.00%0.00%-88.89%KBNTKubient0.00%0.00%0.00%0.00%0.00%KLDOKaleido Biosciences0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDMNGrafiti 0.00N/AN/AN/AGROMGrom Social Enterprises 0.00N/AN/AN/AKBNTKubient 0.00N/AN/AN/AKLDOKaleido Biosciences 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDMNGrafiti$386.09K0.00N/AN/A$173.16 per share0.00GROMGrom Social Enterprises$3.72M0.00N/AN/A$6.25 per share0.00KBNTKubient$1.17M0.00N/AN/AN/A∞KLDOKaleido Biosciences$1.10M0.00N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDMNGrafiti-$45.95M-$84.00N/AN/AN/A-874.43%-1,561.96%-160.38%N/AGROMGrom Social Enterprises-$12.53M-$11.67N/AN/AN/AN/AN/AN/A6/3/2026 (Estimated)KBNTKubient-$13.62M-$0.17N/AN/AN/AN/AN/AN/A5/19/2026 (Estimated)KLDOKaleido BiosciencesN/A-$2.24N/AN/AN/AN/AN/AN/AN/ALatest GROM, KLDO, DMN, and KBNT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/3/2026N/AGROMGrom Social Enterprises-$5.04N/AN/AN/A$1.71 millionN/A5/19/2026N/AKBNTKubient-$0.29N/AN/AN/A$0.40 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDMNGrafitiN/AN/AN/AN/AN/AGROMGrom Social EnterprisesN/AN/AN/AN/AN/AKBNTKubientN/AN/AN/AN/AN/AKLDOKaleido BiosciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDMNGrafiti0.350.460.34GROMGrom Social EnterprisesN/AN/AN/AKBNTKubientN/AN/AN/AKLDOKaleido BiosciencesN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDMNGrafiti11.70%GROMGrom Social Enterprises15.94%KBNTKubient13.91%KLDOKaleido Biosciences81.56%Insider OwnershipCompanyInsider OwnershipDMNGrafiti0.34%GROMGrom Social Enterprises0.01%KBNTKubient22.33%KLDOKaleido Biosciences9.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDMNGrafitiN/A4.62 million706,000N/AGROMGrom Social Enterprises4509.02 million9.02 millionNot OptionableKBNTKubient4014.73 million11.44 millionNo DataKLDOKaleido Biosciences8042.62 million38.79 millionNot OptionableGROM, KLDO, DMN, and KBNT HeadlinesRecent News About These CompaniesKaleido Biosciences Insider Trading Activity | OTC:KLDO | BenzingaApril 20, 2026 | benzinga.comViCentra expects no immediate impact from Dexcom G6 discontinuation on Kaleido pump usersApril 6, 2026 | drugdeliverybusiness.comDKaleido Biosciences Inc.February 18, 2026 | marketwatch.comViCentra Raises $85M to Scale Manufacturing and Accelerate Market Penetration of Kaleido Insulin Patch PumpSeptember 3, 2025 | pharmiweb.comPViCentra prepares for big commercial push with its Kaleido automated insulin patch pumpSeptember 3, 2025 | drugdeliverybusiness.comDKaleido Life Introduces the Third Way to Fund Your Future: Cash. Credit. Kaleido.May 19, 2025 | gritdaily.comGKaleido Biosciences Inc (KLDO)April 10, 2025 | uk.investing.comCelebration As NSW’s First LGBTQIA+ Dedicated Health Service Kaleido Opens Its DoorsApril 9, 2025 | starobserver.com.auSKaleido Intelligence: Transport & Logistics Cellular Data to Surpass 2 Exabytes by 2030April 3, 2025 | thefastmode.comTKaleido, Mobilesquared Announce Merger to Revolutionize Mobile Market IntelligenceJanuary 19, 2025 | thefastmode.comTSyniverse Named Leader in Mobile Roaming by Kaleido Intelligence for Fourth Straight YearDecember 11, 2024 | finance.yahoo.comBICS, Cellusys, Comfone, Mobileum, Syniverse, Telefónica Global Solutions & TOMIA MACH Named Champion Roaming Vendors by Kaleido IntelligenceNovember 25, 2024 | markets.businessinsider.comNew PocketBook Color Note With 10.3-inch E Ink Kaleido 3 Mobius Display LaunchedNovember 1, 2024 | goodereader.comGViCentra wins CE mark for Kaleido insulin pumpOctober 21, 2024 | drugdeliverybusiness.comDKaleido Biosciences (OTC:KLDO) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comKaleido announces the appointment of RBC Investor Services as the new custodian of its scholarship plansOctober 1, 2024 | ca.finance.yahoo.comNew Readmoo mooInk Nana e-Reader With 7-inch Kaleido 3 Display LaunchedSeptember 29, 2024 | goodereader.comGiReader Smart 5C e-Note With 10.3-inch Kaleido 3 to Launch on Sept. 23September 14, 2024 | goodereader.comGOnyx Boox T10C e-Note With Kaleido 3 Display LaunchedSeptember 7, 2024 | goodereader.comGMoaan Pantone 7 e-Reader with Kaleido 3 E-Paper Display Now AvailableAugust 19, 2024 | goodereader.comGNew MarketBeat Followers Over TimeGROM, KLDO, DMN, and KBNT Company DescriptionsGrafiti NASDAQ:DMNGrafiti Holding is the holding company of Grafiti UK, which operates the Grafiti UK Business. Grafiti is a distributor in the UK and certain other European countries of data analytics and visualization software products referred to as “SAVES” primarily for scientists and engineers. Our products can be downloaded to a user's desktop. These products help scientific research in the health and life sciences domain in the discovery of new drugs, in the study of the efficacy of established drugs and therapies, and in epidemic propagation research, among other applications. Engineers use our products for a multitude of applications which include, but are not limited to, conducting surface modelling analysis and curve fitting in order to design new engineering processes, studying signal attenuation and propagation in radio engineering. Potential automobile and motorcycle applications could include surface panel design for aerodynamics, aesthetic symmetry, and calculated asymmetry among others. We believe our regression analysis product could also be used for predicting vehicle sharing demand and pricing trends in various markets based on a wide range of variables. Grafiti Holding was incorporated on October 17, 2023 in British Columbia, Canada. Grafiti UK was formed by the Parent on May 13, 2020 as a distribution arm for its SAVES products in the UK market and part of the European market. Grafiti UK's strategy is to build a broader, long term customer base by increasing its sales of Grafiti UK's product offerings which will include cloud and Macintosh compatible data analytics and statistical visualization software products. We believe this will enable the Grafiti UK Business to focus on generating more recurring revenues in the future. The address of our principal executive office is 268 Bath Road, Slough.Grom Social Enterprises NASDAQ:GROM$0.0001 0.00 (0.00%) As of 05/7/2026 09:30 AM EasternGrom Social Enterprises, Inc., through its subsidiaries, operates as a media, technology, and entertainment company in the United States and Philippines. It operates through three segments: Animation, Original Content, and Social and Technology. The company operates a social media network for children under the age of 13 years. It also produces animated films and televisions series; and provides web filtering services to schools and government agencies, as well as acquires, develops, and builds commercial potential of kids and family entertainment properties and associated business opportunities. Grom Social Enterprises, Inc. was founded in 2012 and is headquartered in Boca Raton, Florida.Kubient NASDAQ:KBNT$0.0001 0.00 (0.00%) As of 11:45 AM EasternKubient, Inc. develops a cloud-based software platform for digital advertising industry. It develops Audience Marketplace, a platform for real-time trading of digital, programmatic advertising. The company's platform allows advertisers and publishers the ability to use machine learning during programmatic advertising inventory auction. The company was incorporated in 2017 and is based in New York, New York.Kaleido Biosciences NASDAQ:KLDO$0.0001 0.00 (0.00%) As of 12:18 PM EasternKaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
